Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Takeda may sell up to $10B in assets to help fund Shire deal

Published 11/30/2018, 12:36 PM
© Reuters.  Takeda may sell up to $10B in assets to help fund Shire deal
  • In an interview, Takeda Pharmaceutical Company (OTCPK:TKPYY +1.6%) CFO Costa Saroukos said that the company could sell up to $10B in non-core assets to help finance its $62B takeout of Shire plc (SHPG +1.9%), twice the amount reported previously.
  • Potential assets on the block are Shire's SHP647 for IBD and certain Takeda OTC products in Europe.
  • 2/3 of Takeda shareholders still have to bless the merger. They will vote at a special meeting on December 5.
  • Previously: Former Takeda chief not on board with Shire deal (Nov. 27)
  • Now read: Hiccup in CVS-Aetna deal approval?


Original article

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.